BENTLEY SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BENTLEY SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $734.85M | Mar 2, 2021 |
| FY2020 | Dec 31, 2018 | $691.71M | Mar 2, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.50B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.35B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.23B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.10B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $965.05M | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $222.01M | May 11, 2021 |
| FY2020 | Dec 31, 2020 | $219.57M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $203.00M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $184.29M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $194.69M | May 11, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.22B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.10B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $962.33M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $862.07M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $748.51M | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $172.72M | May 11, 2021 |
| FY2020 | Dec 31, 2020 | $169.00M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $160.37M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $147.59M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $157.43M | May 11, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $277.86M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $234.79M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $326.79M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $174.78M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $93.19M | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $57.01M | May 11, 2021 |
| FY2020 | Dec 31, 2020 | $51.93M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $5.84M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $39.08M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $29.67M | May 11, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $362.62M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $302.15M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $230.54M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $208.61M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $94.59M | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $55.65M | May 11, 2021 |
| FY2020 | Dec 31, 2020 | $54.28M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $5.32M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $44.59M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $45.96M | May 11, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $307.58M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $281.25M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $274.62M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $257.86M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $220.92M | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $47.80M | May 11, 2021 |
| FY2022 | Dec 31, 2020 | $185.52M | Feb 28, 2023 |
| FY2020 | Mar 31, 2020 | $45.14M | May 11, 2021 |
| FY2021 | Dec 31, 2019 | $183.55M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $175.03M | Mar 2, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $538.46M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $435.29M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $416.70M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $274.32M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $288.02M | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $132.80M | May 11, 2021 |
| FY2022 | Dec 31, 2020 | $258.34M | Feb 28, 2023 |
| FY2020 | Mar 31, 2020 | $72.61M | May 11, 2021 |
| FY2021 | Dec 31, 2019 | $170.77M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $161.47M | Mar 2, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.26M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $14.05M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $25.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $18.55M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $17.54M | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $2.66M | May 11, 2021 |
| FY2022 | Dec 31, 2020 | $16.45M | Feb 28, 2023 |
| FY2020 | Mar 31, 2020 | $4.50M | May 11, 2021 |
| FY2021 | Dec 31, 2019 | $16.64M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $18.62M | Mar 2, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.56B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.40B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.32B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.17B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.66B | Feb 28, 2023 |
| FY2020 | Mar 31, 2021 | $1.63B | May 11, 2021 |
| FY2021 | Dec 31, 2020 | $1.13B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $994.60M | Mar 2, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.37B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.36B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.44B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $2.59B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.25B | Feb 28, 2023 |
| FY2020 | Mar 31, 2021 | $1.27B | May 11, 2021 |
| FY2021 | Dec 31, 2020 | $784.44M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $659.98M | Mar 2, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $883.28M | Feb 26, 2025 |
| FY2021 | Dec 31, 2021 | $409.22M | Mar 1, 2022 |
| FY2020 | Mar 31, 2021 | $354.00M | May 11, 2021 |
| FY2021 | Dec 31, 2020 | $341.60M | Mar 1, 2022 |
| FY2020 | Mar 31, 2020 | $351.01M | May 11, 2021 |
| FY2021 | Dec 31, 2019 | $334.62M | Mar 1, 2022 |
| FY2021 | Dec 31, 2018 | $147.43M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $52.17M | Mar 2, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.48B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.37B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.27B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.24B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.59B | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | $622.76M | May 11, 2021 |
| FY2022 | Dec 31, 2020 | $581.17M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $480.07M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $446.32M | Mar 2, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($40.26M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($75.94M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | ($161.93M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($370.87M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($439.63M) | Feb 28, 2023 |
| FY2020 | Mar 31, 2021 | ($345.98M) | May 11, 2021 |
| FY2021 | Dec 31, 2020 | ($376.00M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($52.67M) | Mar 2, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.28M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $64.01M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $68.41M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $71.68M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $329.34M | Feb 28, 2023 |
| FY2020 | Mar 31, 2021 | $569.54M | May 11, 2021 |
| FY2021 | Dec 31, 2020 | $122.01M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $121.10M | Mar 2, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.39B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.53B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.78B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.44B | Feb 28, 2023 |
| FY2020 | Mar 31, 2021 | $672.60M | May 11, 2021 |
| FY2021 | Dec 31, 2020 | $246.00M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $233.75M | Mar 2, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | 0 | May 11, 2021 |
| FY2020 | Dec 31, 2020 | 0 | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | 0 | May 11, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2020 | Mar 31, 2021 | 0 | May 11, 2021 |
| FY2020 | Dec 31, 2020 | 0 | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | 0 | May 11, 2021 |